Free tool
FAERS Monitor: Chantix
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021928 or its brand name (Chantix, Varenicline Tartrate). Reports on generic versions are filed under their own applications.
Reports
76,596
Serious
31,194
41% of reports
Hospitalization
6,944
Death reported
1,581
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea13,951
- depression8,329
- abnormal dreams7,633
- anxiety5,827
- drug ineffective5,559
- insomnia5,430
- vomiting4,244
- headache4,035
- suicidal ideation4,000
- malaise3,952
- feeling abnormal3,940
- nightmare3,151
- fatigue3,093
- dizziness2,918
- aggression2,723
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 213 |
| 2007 | 3,076 |
| 2008 | 4,745 |
| 2009 | 1,550 |
| 2010 | 29,906 |
| 2011 | 6,391 |
| 2012 | 6,935 |
| 2013 | 3,307 |
| 2014 | 3,575 |
| 2015 | 2,251 |
| 2016 | 2,447 |
| 2017 | 2,396 |
| 2018 | 2,274 |
| 2019 | 2,535 |
| 2020 | 1,792 |
| 2021 | 1,180 |
| 2022 | 1,027 |
| 2023 | 312 |
| 2024 | 218 |
| 2025 | 249 |
| 2026 | 217 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,563 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| abnormal dreamsSignal | 7,633 | 104.5 | 101.9 | 566,972 |
| nightmareSignal | 3,151 | 27.4 | 26.4 | 72,983 |
| aggressionSignal | 2,723 | 15.7 | 15.2 | 35,618 |
| suicidal ideationSignal | 4,000 | 12.5 | 12.1 | 40,641 |
| depressionSignal | 8,329 | 10.4 | 10.2 | 68,876 |
| anxietySignal | 5,827 | 5.7 | 5.6 | 22,525 |
| insomniaSignal | 5,430 | 5.7 | 5.5 | 20,842 |
| nauseaSignal | 13,951 | 4.9 | 4.8 | 44,327 |
| feeling abnormalSignal | 3,940 | 4.6 | 4.4 | 10,941 |
| vomitingSignal | 4,244 | 2.5 | 2.4 | 3,842 |
| malaiseSignal | 3,952 | 2.5 | 2.4 | 3,557 |
| headache | 4,035 | 1.8 | 1.7 | 1,390 |
| dizziness | 2,918 | 1.6 | 1.6 | 686 |
| drug ineffective | 5,559 | 1.2 | 1.1 | 129 |
| fatigue | 3,093 | 1.1 | 1.1 | 24 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.